Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionscaffold protein binding

ADCY5 CACNA1G MYH9

7.59e-0593183GO:0097110
DomainSH3

DOCK4 SPTAN1

1.80e-02216182PS50002
DomainSH3

DOCK4 SPTAN1

1.80e-02216182SM00326
PathwayWP_TGFB_SMAD_SIGNALING

TGFBR2 CCN2

7.92e-0512162M48091
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

PLCB4 CYCS

1.83e-0418162M47659
PathwayKEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY

PLCB4 CYCS

2.27e-0420162M47688
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY

PLCB4 CYCS

2.50e-0421162M47689
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

PLCB4 CYCS

2.75e-0422162M47690
PathwayKEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY

PLCB4 CYCS

2.75e-0422162M47675
PathwayKEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY

PLCB4 CYCS

3.01e-0423162M47676
PathwayKEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY

CACNA1G CYCS

3.01e-0423162M47666
PathwayWP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE

TGFBR2 CCN2

3.57e-0425162M39713
PathwayWP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY

TGFBR2 CCN2

4.49e-0428162M42541
PathwayWP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING

TGFBR2 SLC1A2 PLCB4

4.88e-04140163M42572
PathwayBIOCARTA_DEATH_PATHWAY

SPTAN1 CYCS

6.63e-0434162MM1422
PathwayREACTOME_G_PROTEIN_MEDIATED_EVENTS

ADCY5 PLCB4

8.73e-0439162MM14496
PathwayWP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS

SPTAN1 CYCS

1.11e-0344162M39673
PathwayWP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY

ADCY5 CCN2

1.21e-0346162M39828
PathwayPID_CASPASE_PATHWAY

SPTAN1 CYCS

1.49e-0351162M220
PathwayKEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS

SLC1A2 CYCS

1.61e-0353162M3812
PathwayPID_TGFBR_PATHWAY

TGFBR2 CCN2

1.67e-0354162M286
PathwayREACTOME_G_PROTEIN_MEDIATED_EVENTS

ADCY5 PLCB4

1.67e-0354162M26911
PathwayWP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER

TGFBR2 CCN2

1.67e-0354162M42568
PathwayREACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA

MYH9 SPTAN1

1.73e-0355162M41823
PathwayBIOCARTA_HIVNEF_PATHWAY

SPTAN1 CYCS

1.79e-0356162MM1406
PathwayWP_CANCER_PATHWAYS

TGFBR2 ADCY5 PLCB4 CYCS

2.13e-03507164M48302
PathwayKEGG_COLORECTAL_CANCER

TGFBR2 CYCS

2.20e-0362162M14631
PathwayREACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH

CACNA1G SPTAN1

2.27e-0363162M11187
PathwayREACTOME_SEMAPHORIN_INTERACTIONS

MYH9 SEMA3E

2.34e-0364162M7923
PathwayKEGG_VIRAL_MYOCARDITIS

MYH9 CYCS

2.79e-0370162M12294
PathwayREACTOME_OPIOID_SIGNALLING

ADCY5 PLCB4

2.87e-0371162MM14491
PathwayWP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER

TGFBR2 CYCS

3.03e-0373162M39758
PathwayWP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY

TGFBR2 CCN2

3.11e-0374162M48080
PathwayWP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA

CSMD3 TGFBR2

3.11e-0374162M39857
PathwayREACTOME_SENSORY_PROCESSING_OF_SOUND

MYH9 SPTAN1

3.36e-0377162M41822
PathwayREACTOME_NERVOUS_SYSTEM_DEVELOPMENT

CACNA1G MYH9 SPTAN1 SEMA3E

3.37e-03575164M29853
Pubmed

CCN2 Increases TGF-β Receptor Type II Expression in Vascular Smooth Muscle Cells: Essential Role of CCN2 in the TGF-β Pathway Regulation.

TGFBR2 CCN2

2.83e-07219235008801
Pubmed

Transforming growth factor-β-independent role of connective tissue growth factor in the development of liver fibrosis.

TGFBR2 CCN2

8.48e-07319225108224
Pubmed

Influence of TGFBR2, TGFB3, DNMT1, and DNMT3A Knockdowns on CTGF, TGFBR2, and DNMT3A in Neonatal and Adult Human Dermal Fibroblasts Cell Lines.

TGFBR2 CCN2

8.48e-07319234204856
Pubmed

Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas.

TGFBR2 MYH9

8.48e-07319224436421
Pubmed

Connective tissue growth factor regulates interneuron survival and information processing in the olfactory bulb.

TGFBR2 CCN2

8.48e-07319223993699
Pubmed

ST3GAL1 and βII-spectrin pathways control CAR T cell migration to target tumors.

MYH9 SPTAN1

4.24e-06619237069398
Pubmed

Vector-capping: a simple method for preparing a high-quality full-length cDNA library.

MYH9 SPTAN1

4.24e-06619216106752
Pubmed

Dynamic analysis of the expression of the TGFbeta/SMAD2 pathway and CCN2/CTGF during early steps of tooth development.

TGFBR2 CCN2

5.93e-06719218089935
Pubmed

Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice.

TGFBR2 CCN2

7.90e-06819226699479
Pubmed

CTGF mediates Smad-dependent transforming growth factor β signaling to regulate mesenchymal cell proliferation during palate development.

TGFBR2 CCN2

1.27e-051019223816882
Pubmed

USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells.

MYH9 SPTAN1

1.27e-051019236653359
Pubmed

Genome-wide association study identifies new susceptibility loci for epithelial ovarian cancer in Han Chinese women.

ANKRD30A SEMA3E

1.27e-051019225134534
Pubmed

OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.

MYH9 SPTAN1

1.55e-051119236411454
Pubmed

TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs.

TGFBR2 CCN2

2.20e-051319218095342
Pubmed

Establishment of a Wheat Cell-Free Synthesized Protein Array Containing 250 Human and Mouse E3 Ubiquitin Ligases to Identify Novel Interaction between E3 Ligases and Substrate Proteins.

DZIP3 MSL2

2.20e-051319227249653
Pubmed

The role of TGF-beta signaling in regulating chondrogenesis and osteogenesis during mandibular development.

TGFBR2 CCN2

2.56e-051419217204263
Pubmed

Active conformation of the p97-p47 unfoldase complex.

MYH9 SPTAN1

2.96e-051519235552390
Pubmed

ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex.

TGFBR2 CCN2

2.96e-051519238871984
Pubmed

PRDM16 controls a brown fat/skeletal muscle switch.

CKM CYCS

4.81e-051919218719582
Pubmed

Transcriptome of the inner circular smooth muscle of the developing mouse intestine: Evidence for regulation of visceral smooth muscle genes by the hedgehog target gene, cJun.

TGFBR2 ADCY5 PLCB4

5.90e-0514019326930384
Pubmed

Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes.

MYH9 SPTAN1

5.90e-052119212202484
Pubmed

Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.

SLC1A2 ADCY5 MYH9 SPTAN1

6.00e-0540319430562941
Pubmed

Constitutive activation of hedgehog signaling adversely affects epithelial cell fate during palatal fusion.

TGFBR2 MYH9

7.10e-052319229981310
Pubmed

Majority of cerebrospinal fluid-contacting neurons in the spinal cord of C57Bl/6N mice is present in ectopic position unlike in other studied experimental mice strains and mammalian species.

ADCY5 ARMCX4

7.75e-052419232212159
Pubmed

Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.

DOCK4 MYH9 SPTAN1

8.14e-0515619322952844
Pubmed

NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy.

MYH9 SPTAN1

8.42e-052519230309841
Pubmed

The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus.

DOCK4 MYH9 SPTAN1

1.03e-0416919323084401
Pubmed

A human MAP kinase interactome.

SLC1A2 MYH9 SPTAN1 MSL2

1.24e-0448619420936779
Pubmed

Genome-wide association study of periodontal pathogen colonization.

ANKRD30A CSMD3

1.30e-043119222699663
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

DZIP3 SLC1A2 MYH9 SPTAN1 ARMCX4

1.36e-0496319528671696
Pubmed

Huntingtin interacting proteins are genetic modifiers of neurodegeneration.

CKM SLC1A2 SPTAN1

1.62e-0419719317500595
Pubmed

Reverse engineering a mouse embryonic stem cell-specific transcriptional network reveals a new modulator of neuronal differentiation.

MYH9 SPTAN1

1.86e-043719223180766
Pubmed

The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.

SLC1A2 MYH9 SPTAN1 CYCS

2.01e-0455219436293380
Pubmed

SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication.

CCN2 MYH9 SPTAN1

2.13e-0421619337640791
Pubmed

A proteomic snapshot of the human heat shock protein 90 interactome.

MYH9 SPTAN1

2.18e-044019216263121
Pubmed

Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.

CKM MYH9 SPTAN1 CYCS

2.19e-0456419421565611
Pubmed

Quantitative nanoproteomics for protein complexes (QNanoPX) related to estrogen transcriptional action.

MYH9 SPTAN1

2.29e-044119219805454
Pubmed

An emerin "proteome": purification of distinct emerin-containing complexes from HeLa cells suggests molecular basis for diverse roles including gene regulation, mRNA splicing, signaling, mechanosensing, and nuclear architecture.

MYH9 SPTAN1

3.14e-044819217620012
Pubmed

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.

DDX55 MYH9 SPTAN1

3.27e-0425019333536335
Pubmed

Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.

DDX55 DZIP3 SPTAN1 CYCS

3.64e-0464519425281560
Pubmed

Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.

CACNA1G CYCS

3.83e-045319223535033
Pubmed

CIN85 interacting proteins in B cells-specific role for SHIP-1.

MYH9 SPTAN1

3.98e-045419221725061
Pubmed

Identification of host proteins required for HIV infection through a functional genomic screen.

DDX55 ANKRD30A SPTAN1

4.18e-0427219318187620
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

DDX55 CKM MYH9 PLCB4 SPTAN1

5.37e-04129719533545068
Pubmed

DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis.

MYH9 SPTAN1

5.41e-046319237052853
GeneFamilyRing finger proteins

DZIP3 MSL2

2.40e-0227516258
CoexpressionTRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL

DOCK4 TGFBR2 CCN2 SPTAN1 SEMA3E

7.05e-06391195M41659
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HNBGABA

DOCK4 CSMD3 SLC1A2 CACNA1G PLCB4 SEMA3E

7.34e-06703196M39070
CoexpressionGSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN

TGFBR2 STAG3 CCN2 MYH9

1.10e-05197194M3438
CoexpressionMARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1

MYH9 PLCB4

1.39e-058192M2045
CoexpressionGU_PDEF_TARGETS_UP

DOCK4 CCN2 PLCB4

1.79e-0571193M3955
CoexpressionJONES_OVARY_NK_CELL

TGFBR2 CCN2 MYH9

3.53e-0589193M48353
CoexpressionKAYO_CALORIE_RESTRICTION_MUSCLE_UP

TGFBR2 MYH9 SPTAN1

4.15e-0594193M7013
CoexpressionHEVNER_CORTEX_VASCULAR_ENDOTHELIAL_CELLS

TGFBR2 MYH9

8.45e-0519192MM420
CoexpressionMANNO_MIDBRAIN_NEUROTYPES_HGABA

DOCK4 CSMD3 SLC1A2 CACNA1G PLCB4 SEMA3E

9.41e-051106196M39071
CoexpressionLAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR

DOCK4 MYH9 PLCB4

1.73e-04152193M39243
CoexpressionGROSS_HYPOXIA_VIA_ELK3_DN

DZIP3 CCN2 MYH9

1.83e-04155193M1304
CoexpressionGROSS_HYPOXIA_VIA_ELK3_DN

DZIP3 CCN2 MYH9

2.01e-04160193MM1126
CoexpressionMULLIGHAN_NPM1_SIGNATURE_3_DN

TGFBR2 PLCB4 SPTAN1

2.05e-04161193M15047
CoexpressionMURARO_PANCREAS_DUCTAL_CELL

TGFBR2 ADCY5 CCN2 MYH9 SPTAN1 CYCS

2.06e-041276196M39173
CoexpressionJONES_OVARY_ENDOTHELIAL

TGFBR2 CCN2 MYH9

2.09e-04162193M48350
CoexpressionTSAI_RESPONSE_TO_RADIATION_THERAPY

TGFBR2 CCN2

2.44e-0432192M308
CoexpressionJONES_OVARY_PERICYTE

TGFBR2 CCN2 MYH9

2.49e-04172193M48351
CoexpressionLAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED

MYH9 PLCB4

3.45e-0438192M39244
CoexpressionHALLMARK_MITOTIC_SPINDLE

DOCK4 MYH9 SPTAN1

3.82e-04199193M5893
CoexpressionGSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN

DZIP3 MYH9 ARMCX4

3.88e-04200193M9492
CoexpressionGSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP

DDX55 STAG3 MYH9

3.88e-04200193M5089
CoexpressionGSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN

TGFBR2 PLCB4 ARMCX4

3.88e-04200193M5073
CoexpressionGSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN

TGFBR2 PLCB4 MSL2

3.88e-04200193M7502
CoexpressionGSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP

DOCK4 TGFBR2 SPTAN1

3.88e-04200193M6613
CoexpressionGSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP

MYH9 SPTAN1 CYCS

3.88e-04200193M5185
CoexpressionHALLMARK_MYOGENESIS

CKM MYH9 SPTAN1

3.88e-04200193M5909
CoexpressionDUTERTRE_ESTRADIOL_RESPONSE_24HR_DN

DZIP3 TGFBR2 CCN2 MYH9

4.16e-04504194M2157
CoexpressionULE_SPLICING_VIA_NOVA2

PLCB4 SPTAN1

4.42e-0443192MM666
CoexpressionULE_SPLICING_VIA_NOVA2

PLCB4 SPTAN1

4.42e-0443192M1551
CoexpressionLAKE_ADULT_KIDNEY_C2_PODOCYTES

DOCK4 CCN2 MYH9

4.59e-04212193M39221
CoexpressionTAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN

CACNA1G SPTAN1

4.84e-0445192M10084
CoexpressionSATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2

STAG3 CACNA1G

5.28e-0447192M9702
CoexpressionSATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER

CACNA1G CCN2

5.28e-0447192M11213
CoexpressionKYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP

CCN2 CYCS

6.71e-0453192M14365
CoexpressionJONES_OVARY_MACROPHAGE

TGFBR2 CCN2 MYH9

6.83e-04243193M48355
CoexpressionLEE_LIVER_CANCER_MYC_UP

SLC1A2 CCN2

6.97e-0454192M2742
CoexpressionDANG_REGULATED_BY_MYC_DN

TGFBR2 CCN2 SPTAN1

7.51e-04251193M2310
CoexpressionGAUTAM_EYE_IRIS_CILIARY_BODY_SMOOTH_MUSCLE_CELLS

ADCY5 CCN2 CYCS

9.07e-04268193M43619
CoexpressionJECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN

CCN2 MYH9

9.17e-0462192M1417
CoexpressionJECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN

CCN2 MYH9

9.47e-0463192MM1147
CoexpressionAtlasDevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000

CKM ADCY5 CCN2 MYH9 PLCB4 SEMA3E

4.09e-05772196gudmap_developingLowerUrinaryTract_P1_bladder_1000_J
CoexpressionAtlasDevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000

DZIP3 ADCY5 CCN2 MYH9 PLCB4 SEMA3E

4.09e-05772196gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CSMD3 SLC1A2 CACNA1G SEMA3E

1.14e-061901946c7e1086c0a274cd5527c3104106e372811c9905
ToppCellControl-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations)

SLC1A2 ADCY5 PLCB4

2.70e-05139193e769beb031b262dd92c9605b07dbf3c29fb82520
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

ADCY5 CCN2 PLCB4

3.95e-0515819384c0a215dabf697ada036c2b9592d0c61b5077de
ToppCellNS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ANKRD30A DOCK4 ADCY5

4.58e-051661936d9fb239f69ba519844f593c00d515e1aac4ff50
ToppCelldroplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSMD3 CACNA1G SEMA3E

4.66e-05167193e1b1a952fce27ab9cf16919b290625ff4a75261e
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CCN2 PLCB4 SEMA3E

5.26e-0517419343c0e758fa8683708475aec846929ac70d41d7f5
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CCN2 PLCB4 SEMA3E

5.26e-0517419399eb5e1aee136c7039e23b68a43a0fa3d775859f
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CCN2 PLCB4 SEMA3E

5.26e-05174193e4d65fe121a32ac4cdd6312e7b8f867f0852e991
ToppCell3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD30A ADCY5 PLCB4

5.54e-05177193daaccf1249dcf816df4caca695a944f53078291a
ToppCell3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD30A ADCY5 PLCB4

5.54e-051771936d89042bda8e244babb68929e84b25edcb545a77
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CCN2 PLCB4 SEMA3E

5.54e-051771934c069f0d044a96118090b85ca592a21d6b5d9399
ToppCell3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD30A ADCY5 PLCB4

5.54e-05177193c5a16f984c836dbf7d0faf061677844167ab612a
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9

DZIP3 CSMD3 SPTAN1

5.54e-05177193e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD30A ADCY5 PLCB4

5.54e-05177193338bdda26796bf4e16072878c070212d1006cf57
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSMD3 CACNA1G SEMA3E

5.73e-051791937c8a2fa1326c73dc9e774df645b572864fd97133
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CCN2 PLCB4 SEMA3E

5.73e-05179193f65889bf1e41396979cce44a5e63f49dea2bbd9b
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CCN2 PLCB4 SEMA3E

5.82e-05180193e8841ef1239f9ee73ac4f4e11faca0742694f368
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CCN2 PLCB4 SEMA3E

5.92e-0518119308f44323bf71b6004a921bbc969c954c75feeb66
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CCN2 PLCB4 SEMA3E

6.11e-0518319365f2a5895d166189a095cf7ea9dda171f0419b08
ToppCell3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD30A ADCY5 PLCB4

6.21e-05184193a60802e11dcc5f932811260b08a95a32f60f6b19
ToppCell3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD30A ADCY5 PLCB4

6.21e-051841932a2fb691cc9414ef5b06c26239d2da03d6d7e5c2
ToppCell3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ANKRD30A ADCY5 PLCB4

6.21e-0518419339c230d32e4259bc784e0edfd9e2884c96898564
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

CACNA1G PLCB4 SEMA3E

6.52e-051871935258674d0346e5c51a4b965efcdc1790c970845d
ToppCelldroplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSMD3 ADCY5 CCN2

6.62e-05188193d1a4cd4db95d8d32b79156290f7867f32824cc87
ToppCellASK454-Epithelial-Type_1|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

TGFBR2 CCN2 SPTAN1

6.62e-0518819313f8ce8f24ac7d7ed87f4ae3b8f4096de29383c2
ToppCellGlobus_pallidus-Endothelial|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

TGFBR2 CCN2 MYH9

6.73e-05189193ad7dc9d25edd68fb624380a082c389fe7d640e7d
ToppCellrenal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK4 ADCY5 MYH9

6.83e-05190193f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK4 TGFBR2 PLCB4

7.05e-051921931ee4783051ec94ea94600f040edcb385fc4289f1
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADCY5 CCN2 PLCB4

7.16e-051931939a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3
ToppCellPND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADCY5 CCN2 PLCB4

7.16e-051931937c7aa5e2124830d0fa1df11b6413ec6cf780aad0
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CCN2 MYH9 PLCB4

7.27e-05194193a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADCY5 CCN2 PLCB4

7.38e-0519519356e7cd980f8fc2dae842e6a7bd919d4b41cebbbb
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ADCY5 CCN2 PLCB4

7.38e-05195193a28a504c69bc4dda7de023e1b4ea4f62390b158e
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CSMD3 SLC1A2 SEMA3E

7.49e-05196193671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCellBronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ADCY5 CCN2 PLCB4

7.49e-05196193a58bdf9de05d13d84211e09a933679d485bf8ab4
ToppCell10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CSMD3 SLC1A2 SEMA3E

7.49e-05196193f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell(4)_Endothelial_cells|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

TGFBR2 CCN2 PLCB4

7.61e-05197193dd9abb43c23e7698433e455eacbf5b23b0a756c2
ToppCell(4)_Blood_vessel|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

TGFBR2 CCN2 PLCB4

7.61e-051971931b82979a41ef46c814c82527a585900586d71260
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CSMD3 CCN2 MYH9

7.72e-0519819309be07ebfc3e49c3858e9b74605b69cf4fc28b56
ToppCellEpithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id

CCN2 MYH9 SPTAN1

7.72e-05198193fbc46b20bcd44f2083170aacbc6f5dd00fba685c
ToppCellASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

DOCK4 CCN2 SEMA3E

7.72e-051981930047a9ef7684230ac5179efea94461480e90bdaf
ToppCellASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

TGFBR2 CCN2 SEMA3E

7.84e-0519919348cafe44951908d03f3c6f3e185e9cbb86fb5b3b
ToppCellControl_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

TGFBR2 PLCB4 SPTAN1

7.96e-052001933372c488a39fe812fa94e4f0564594186fea3db5
ToppCellNeuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SCUBE1|Neuronal / cells hierarchy compared to all cells using T-Statistic

SLC1A2 CCN2 SEMA3E

7.96e-05200193012dd2180f6f596d6e55e864be2e62b53c15edb2
ToppCellNeuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SCUBE1-|Neuronal / cells hierarchy compared to all cells using T-Statistic

SLC1A2 CCN2 SEMA3E

7.96e-0520019306f949c81eecba00203f0716d0c5854724871184
ToppCellLPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

TGFBR2 PLCB4 SPTAN1

7.96e-05200193a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCellLung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TGFBR2 CCN2 MYH9

7.96e-05200193e6d36be0c4c569e27303bb4e4f34cd2187e9759d
ToppCellParenchyma_COVID-19-Endothelial-TX-Macrophages|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

TGFBR2 CCN2 MYH9

7.96e-05200193c0c51719cf81512c50bfcc2fed883c867e522d2a
ToppCellNeuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2|Neuronal / cells hierarchy compared to all cells using T-Statistic

SLC1A2 CCN2 SEMA3E

7.96e-05200193d31e26387d879ee30731c497cea6aaf4746e40d9
ToppCellControl_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

TGFBR2 PLCB4 SPTAN1

7.96e-05200193e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCellLPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

TGFBR2 PLCB4 SPTAN1

7.96e-052001931d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCellNeuronal-Excitatory-eD(FEZF2)|Neuronal / cells hierarchy compared to all cells using T-Statistic

DOCK4 SLC1A2 SEMA3E

7.96e-052001931b485ff2435c6732be58cbc9eb2f5c273f9c4bf2
ToppCell3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DOCK4 TGFBR2 CCN2

7.96e-05200193cee07d9370656e1c428a7a9e9fbd175129901374
ToppCellLPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

TGFBR2 PLCB4 SPTAN1

7.96e-05200193d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCellNeuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SCUBE1--L6|Neuronal / cells hierarchy compared to all cells using T-Statistic

SLC1A2 CCN2 SEMA3E

7.96e-0520019357e8aea2c2f736ce37940dceb36224552dc33da1
ToppCellLung_Parenchyma-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

TGFBR2 CCN2 MYH9

7.96e-05200193758840c31f2ddd7ccf7bf13252ebb48d33e89479
ToppCellLPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

TGFBR2 PLCB4 SPTAN1

7.96e-0520019360d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DOCK4 TGFBR2 CCN2

7.96e-05200193074b5766c61fa8e61d0b1b76688ea0d1ec401e5b
ToppCellLung_Parenchyma-Severe-Myeloid-Macrophage-Macrophages|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

TGFBR2 CCN2 MYH9

7.96e-05200193c37fe06a94e5779c56e01389869bb432d3bbaebc
ToppCellASK428-Endothelial-Endothelium|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq

DOCK4 CCN2

1.37e-0441192a72d926de3dc9e420b80764af88002e436517790
ToppCellmetastatic_Lymph_Node-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass

CCN2 MYH9

4.36e-0473192116259a036373bccaeb77fe3c675741a5ca81c52
ToppCell367C-Myeloid-Macrophage-SPP1+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells)

CSMD3 PLCB4

5.37e-04811928cb94dda18010b3b05e5ab72235850483013c03a
ToppCellControl-Epithelial_alveolar-Mes-Like|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DDX55 MSL2

1.10e-03116192df7609503782d8d7e4f31ed2a626916e5474d5bc
ToppCellPosterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32

SLC1A2 SEMA3E

1.21e-0312219237612ad087d9c11d4a3466244ab36224de31930b
ToppCellCOVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type

CSMD3 CKM

1.25e-03124192d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9
ToppCelldroplet-Liver-nan-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK4 ARMCX4

1.31e-0312719239fa20a55de3af1a62ab5dfa4877879db3935ac2
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

SLC1A2 SEMA3E

1.37e-0313019205d5a73acf1d7f75a79876b1a06d27c74a89b8a4
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SLC1A2 CACNA1G

1.57e-03139192505bf5a483fc2ba69377db9850c3b26ab2f416d1
ToppCelldroplet-Pancreas-Exocrine-18m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK4 TGFBR2

1.63e-03142192bf4a9633d128805a0d7e426d6fe6c29db1ff8c81
ToppCellSmart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_monocytic-intermediate_monocyte|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DOCK4 CACNA1G

1.63e-031421929b39c778cfaf457303010f1b1cae8c0cd8fe5d1d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK4 TGFBR2

1.72e-03146192281144e293e8c93a425c2606d2188cb2838e667f
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANKRD30A CSMD3

1.77e-03148192d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCellfrontal_cortex-Neuronal-glutamatergic_neuron-NP-L5_NP_ALM_Trhr_Nefl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CCN2 SEMA3E

1.80e-03149192558a441804dbcd5b5f39a3b1933b48976711ff15
ToppCellE16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass

DOCK4 SLC1A2

1.80e-03149192651494e84be03dc7b061ebdfa91756a1c507b9b4
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CSMD3 SEMA3E

1.80e-03149192a22417286de8606f0cc94f86b70bce17aeefb9c2
ToppCellASK454-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq

TGFBR2 CCN2

1.80e-03149192078792d5272f1881757dc47daa96e87449cf5d34
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CSMD3 SEMA3E

1.80e-03149192c5eedb54ef2e0f131aa6730612c921bc19479632
ToppCell3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADCY5 CCN2

1.82e-03150192aa11579a57d671a55e64183d35c1340fda6dec14
ToppCellCOVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type

ANKRD30A CSMD3

1.82e-031501920205318a870e091add66ee4305747dda9f51510d
ToppCelldroplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSMD3 SEMA3E

1.87e-03152192d88d68a788a3256671ebbc06e104833f1f58f07d
ToppCelldroplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CSMD3 SEMA3E

1.87e-03152192d5ba87b5d34e52cef8475befafea962d70fa8a1d
ToppCell3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ADCY5 CCN2

1.89e-0315319282b77c8bae49dd63b8f10eb67df66ca71d0bb315
ToppCellLeuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type

SPTAN1 SEMA3E

1.89e-03153192b24c693b142206d13b29c96faa7f79a1a22bc2ef
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC1A2 STAG3

1.92e-031541925ed64bbf603290e6dc34f81d145982690b89dd0d
ToppCell10x5'-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue

STAG3 CCN2

1.92e-031541928a8c3851888ab86ca2b13ccc042cde1fef8d88f8
ToppCellChildren_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ADCY5 CCN2

1.94e-03155192cd7d95cbcad248670e531d80bb83c55e36ebc573
ToppCelldroplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC1A2 MSL2

1.97e-03156192d72c2f5f72d269e29033f8728d924e0d4c8772c7
ToppCellfacs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKM SLC1A2

1.99e-031571928a393eece90fb9a1b7c356736bdb36277261fbd3
ToppCellfacs-Heart-Unknown-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKM SLC1A2

1.99e-031571922ac4695d9e4ca8d4ba19c555e9a1d86ac8f398ab
ToppCellfacs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKM SLC1A2

1.99e-031571928d30d8e6fae93afcada6bd68799439335cd65b69
ToppCellAdult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor

ADCY5 PLCB4

2.01e-031581928d64c0c9de910a3f4658778642d183c8b9b6f6a2
ToppCellfacs-Heart-RV-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CKM STAG3

2.01e-031581922ef43d14ee65d004dc62c12ff209bbe12e4db681
ToppCellIPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class

ADCY5 PLCB4

2.07e-03160192d65d19f4fae60836bfd4303a1bb7de34e9d83e35
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor

ADCY5 PLCB4

2.07e-03160192d783d29150033e9181c0e30870070268fed3fd85
ToppCellIPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class

ADCY5 PLCB4

2.09e-03161192f1cd5c938cdc08ad8995371b72493850a6cf277a
ToppCellAdult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor

ADCY5 PLCB4

2.09e-0316119264891f6f2ee1693c8481e951b9346e2f92d602e3
ToppCellVE-mono3|VE / Condition, Cell_class and T cell subcluster

DOCK4 CACNA1G

2.09e-031611927df3fefc55ab43b897fc78d1f0c7383b10ac33d5
ToppCell367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DZIP3 PLCB4

2.09e-0316119222fea192cd5f6d3544533d8b10e1d74dfedf0f05
ToppCellVE-mono3-|VE / Condition, Cell_class and T cell subcluster

DOCK4 CACNA1G

2.09e-031611924e45bf7eceb0ee30dec4d8852778366776ea5a8f
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CACNA1G CCN2

2.12e-03162192b936f8040dcd4db621ccded19237af8df7d0ed6e
ComputationalActin cytoskeleton binding.

MYH9 SPTAN1

2.68e-043092MODULE_524
ComputationalGenes in the cancer module 419.

MYH9 SPTAN1

3.45e-043492MODULE_419
Drug3,3',5,5'-tetrahydroxystilbene

SPTAN1 CYCS

9.88e-066192ctd:C551466
DrugIoxaglic acid [59017-64-0]; Down 200; 3.2uM; HL60; HT_HG-U133A

DZIP3 DOCK4 TGFBR2 STAG3

1.83e-051951942966_DN
DrugCeforanide [60925-61-3]; Down 200; 7.6uM; HL60; HT_HG-U133A

DOCK4 STAG3 PLCB4 SPTAN1

1.94e-051981942447_DN
Drugcyclophorine

CKM ADCY5 CACNA1G CCN2 CYCS

2.10e-05426195CID000002909
DrugAC1L1TJF

CKM ADCY5 CACNA1G

2.18e-0566193CID000003377
DrugAC1L1JYL

TGFBR2 ADCY5 CCN2 PLCB4 CYCS

2.29e-05434195CID000005262
DrugAcetylcysteine

CKM TGFBR2 SLC1A2 CACNA1G CCN2 CYCS

2.94e-05780196ctd:D000111
Drug4-hydroxynonenal

SLC1A2 ADCY5 CCN2 PLCB4 CYCS

3.39e-05471195CID000001693
Drugthemisone

CKM CACNA1G

4.33e-0512192CID000016235
Drugcinnamic aldehyde

SLC1A2 CCN2 MYH9 CYCS

4.61e-05247194ctd:C012843
DrugN-ethylmaleimide

CKM ADCY5 MYH9 SPTAN1 CYCS

5.00e-05511195CID000004362
DrugCocaine

CKM SLC1A2 CCN2 MYH9 SPTAN1 SEMA3E CYCS

5.72e-051314197ctd:D003042
DrugReidispongiolide C

SLC1A2 CCN2 SEMA3E CYCS

7.40e-05279194CID005289285
Drug2-chloroadenosine

ADCY5 PLCB4 CYCS

8.03e-05102193CID000008974
Drugguanosine 3',5'-cyclic monophosphoric acid

ADCY5 CACNA1G PLCB4 SEMA3E CYCS

8.90e-05577195CID000000295
DrugAC1L1G32

SLC1A2 CYCS

1.12e-0419192CID000003504
Drugtrifluoperazine

ADCY5 MYH9 SPTAN1 CYCS

1.32e-04324194CID000005566
Drugcrocin

CKM CYCS

1.65e-0423192ctd:C029036
DrugAC1L40MO

CKM SLC1A2 CYCS

1.76e-04133193CID000099067
Drug4-mercaptopyridine

CKM CYCS

1.80e-0424192CID002723889
Drugiloprost

CKM ADCY5 CCN2

1.80e-04134193CID005311181
Drugeye gene

ADCY5 CCN2 MYH9 PLCB4

2.17e-04369194CID000004782
Drugtacrine

SLC1A2 ADCY5 CYCS

2.23e-04144193CID000001935
Drugcandesartan cilexetil

TGFBR2 CCN2

2.46e-0428192ctd:C077793
Druglead compounds

ADCY5 CACNA1G PLCB4

2.51e-04150193CID000073212
Drugpropidium iodide

SLC1A2 MYH9 CYCS

2.56e-04151193CID000004939
Drugcobalt-60

SLC1A2 ADCY5 CACNA1G CYCS

2.68e-04390194CID000061492
DrugBleomycin

SLC1A2 CCN2 SPTAN1 CYCS

3.68e-04424194ctd:D001761
Drug1,1'-azobis(N,N-dimethylformamide

ADCY5 SPTAN1 CYCS

3.82e-04173193CID000004278
Drugsalvianolic acid B

TGFBR2 CYCS

3.86e-0435192ctd:C076944
DrugU0126

CKM TGFBR2 CCN2 CYCS

3.88e-04430194CID000005637
DrugTMB-8

ADCY5 CACNA1G CYCS

4.02e-04176193CID000005494
Drugpapaverine

ADCY5 CACNA1G PLCB4

4.02e-04176193CID000004680
Drugcarboxyatractyloside

CKM CYCS

4.09e-0436192CID000036403
Drug2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester

SLC1A2 CACNA1G CCN2 PLCB4 SEMA3E

4.24e-04807195ctd:C548651
DrugNMMO

CKM SLC1A2

4.32e-0437192CID000082029
Drugsphingosine 1-phosphate

CCN2 PLCB4

4.32e-0437192ctd:C060506
DrugLY 294002; Up 200; 10uM; HL60; HT_HG-U133A

DZIP3 DOCK4 SPTAN1

4.57e-041841932696_UP
Drugaluminum

ADCY5 PLCB4 CYCS

4.57e-04184193CID000104727
DrugSAHA; Up 200; 10uM; HL60; HT_HG-U133A

DZIP3 DOCK4 SPTAN1

4.65e-041851932680_UP
DrugLY 294002; Up 200; 10uM; HL60; HT_HG-U133A

DZIP3 DOCK4 SPTAN1

4.72e-041861931177_UP
Drugtroglitazone; Down 200; 10uM; PC3; HT_HG-U133A

TGFBR2 STAG3 CCN2

4.95e-041891931232_DN
Drugallodeoxycholic acid

CKM PLCB4 CYCS

5.02e-04190193CID000002987
DrugNSC759576

CKM ADCY5 CACNA1G

5.10e-04191193CID000003075
DrugNitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A

DOCK4 CACNA1G CCN2

5.18e-041921933087_UP
DrugHycanthone [3105-97-3]; Down 200; 11.2uM; PC3; HT_HG-U133A

DZIP3 TGFBR2 STAG3

5.26e-041931934630_DN
DrugKainic Acid

SLC1A2 SPTAN1 CYCS

5.34e-04194193ctd:D007608
DrugMegestrol acetate [595-33-5]; Up 200; 10.4uM; MCF7; HT_HG-U133A

DZIP3 SLC1A2 CACNA1G

5.50e-041961936468_UP
DrugHexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; PC3; HT_HG-U133A

TGFBR2 STAG3 SPTAN1

5.58e-041971936620_DN
DrugPirenperone [ 75444-65-4]; Down 200; 10.2uM; PC3; HT_HG-U133A

DZIP3 STAG3 SPTAN1

5.58e-041971934679_DN
DrugEsculin Hydrate [531-75-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A

TGFBR2 STAG3 CCN2

5.58e-041971933390_UP
DrugAminocaproic acid [60-32-2]; Up 200; 30.4uM; PC3; HT_HG-U133A

DZIP3 CACNA1G SPTAN1

5.58e-041971937258_UP
Drug(S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; HL60; HT_HG-U133A

DZIP3 TGFBR2 PLCB4

5.66e-041981932961_DN
DrugCarbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; HL60; HT_HG-U133A

DZIP3 SLC1A2 CACNA1G

5.66e-041981932725_UP
DrugMeclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; HL60; HT_HG-U133A

DZIP3 TGFBR2 CACNA1G

5.66e-041981932424_UP
DrugAG-028671 [847803-03-6]; Down 200; 10uM; PC3; HT_HG-U133A

STAG3 CCN2 SPTAN1

5.66e-041981936557_DN
DrugMefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; MCF7; HT_HG-U133A

TGFBR2 SLC1A2 CACNA1G

5.66e-041981932284_UP
Drugfluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A

DZIP3 STAG3 SPTAN1

5.66e-041981931237_DN
DrugCanrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A

DOCK4 TGFBR2 CACNA1G

5.66e-041981932228_UP
DrugAmodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A

TGFBR2 SLC1A2 SEMA3E

5.75e-041991933186_UP
DrugThiethylperazine malate [52239-63-1]; Down 200; 6uM; PC3; HT_HG-U133A

DZIP3 TGFBR2 STAG3

5.75e-041991935756_DN
DrugSulfabenzamide [127-71-9]; Down 200; 14.4uM; PC3; HT_HG-U133A

DZIP3 TGFBR2 SPTAN1

5.75e-041991936634_DN
DrugVitamin A

TGFBR2 SLC1A2 CYCS

5.83e-04200193ctd:D014801
DrugSuxibuzone [27470-51-5]; Up 200; 9.2uM; HL60; HT_HG-U133A

DZIP3 CACNA1G SPTAN1

5.83e-042001932503_UP
Drugverapamil

CKM ADCY5 CACNA1G MYH9

6.35e-04490194CID000002520
Drugaminophylline

ADCY5 CYCS

6.39e-0445192CID000009433
DrugCalcium

ADCY5 CACNA1G SPTAN1 CYCS

6.50e-04493194ctd:D002118
DrugAsbestos

TGFBR2 CCN2 PLCB4

6.81e-04211193ctd:D001194
DrugAC1Q5THZ

CKM ADCY5 PLCB4 CYCS

6.96e-04502194CID000001959
DrugLypressin

ADCY5 PLCB4

6.97e-0447192CID000005772
Drugphorbol acetate myristate

SLC1A2 ADCY5 CACNA1G MYH9 PLCB4 CYCS

7.21e-041399196CID000004792
DrugCID5288005

CKM CYCS

7.27e-0448192CID005288004
DrugDaunorubicin

CKM CACNA1G CYCS

7.29e-04216193ctd:D003630
DrugAC1L1FA8

SLC1A2 ADCY5

7.89e-0450192CID000003150
Diseasetype 2 diabetes mellitus (biomarker_via_orthology)

TGFBR2 ADCY5 CCN2

9.36e-05147183DOID:9352 (biomarker_via_orthology)
Diseasethrombocytopenia (is_implicated_in)

MYH9 CYCS

1.22e-0427182DOID:1588 (is_implicated_in)
DiseaseIschemia

CKM CYCS

1.32e-0428182C0022116
DiseaseHyalinosis, Segmental Glomerular

CCN2 MYH9

1.32e-0428182C0086432
DiseaseFocal glomerulosclerosis

CCN2 MYH9

2.19e-0436182C0017668
Diseasedimethylglycine measurement

CSMD3 CACNA1G

3.58e-0446182EFO_0010476
Diseasepulmonary fibrosis (biomarker_via_orthology)

TGFBR2 CCN2

4.23e-0450182DOID:3770 (biomarker_via_orthology)
DiseaseHuntington's disease (is_marker_for)

SLC1A2 CYCS

4.75e-0453182DOID:12858 (is_marker_for)
Diseasepulmonary hypertension (biomarker_via_orthology)

TGFBR2 CCN2

1.08e-0380182DOID:6432 (biomarker_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
KCGRLDFILMKKMGI

CSMD3

26

Q7Z407
TGKMEQMKKKFCVLK

ANKRD30A

986

Q9BXX3
ECRGVVKVKGKGEMM

ADCY5

1236

O95622
KAKAKCKTGPGMDMK

ARMCX4

531

Q5H9R4
VKGVKIMCIHGKMKY

DDX55

291

Q8NHQ9
KGFMDGKQACVLMIK

MYH9

731

P35579
VCKTCKGKKMMMKPS

MSL2

66

Q9HCI7
KKCLKEGCTGDMVRM

DZIP3

311

Q86Y13
RDCMKMGEVDGKKIG

DOCK4

1166

Q8N1I0
MGDVEKGKKIFIMKC

CYCS

1

P99999
EMVVKMVALGIFGKK

CACNA1G

131

O43497
KCPDGEVMKKNMMFI

CCN2

306

P29279
TKMVIKKGLEFKDGM

SLC1A2

226

P43004
KAMKKKGGSNCLEMK

PLCB4

981

Q15147
GVKLMVEMEKKLEKG

CKM

356

P06732
CIMKEKKKPGETFFM

TGFBR2

121

P37173
CGCKGIVTPEMFKKM

STAG3

141

Q9UJ98
EKRKGMLEKSCKKFM

SPTAN1

1081

Q13813
KMEECIMKGKDAGEC

SEMA3E

101

O15041